Probiotic-Based Intranasal Vaccine Effective Against House Dust Mite Allergy
An intranasal vaccine consisting of recombinant Lactobacillus plantarum as a vector to deliver mite allergen Der p 1 is effective against house dust mite allergy in a mouse model, according to a report in the March issue of Allergy ...
[read article]

Budesonide Nasal Wash May Be Safe, Effective for Chronic Rhinosinusitis
Budesonide nasal wash may be clinically effective in decreasing symptoms of chronic rhinosinusitis without suppression of the hypothalamic-pituitary-adrenal axis, according to the results of an open-label, prospective study reported in the March issue of the Archives of ...
[read article]

Skin Tests Useful for Diagnosis of Contrast Media Allergy
The results of a prospective European multicenter study suggest that skin testing is a useful tool for the diagnosis of allergy to iodinated contrast media and perhaps in the selection of a safe product to use for patients with a previous hypersensitivity reaction to contrast media...
[read article]

Measles Infection May Protect Against Allergic Disease in Children
A large study of children in Europe has demonstrated an inverse association between measles infection and development of allergiesThe prevalence of allergic disorders has increased during past decades, coinciding with reduced rates of many childhood infections and increasing use of vaccinations, Helen Rosenlund, at Karolinska Institutet in Stockholm, and co-authors note in the March issue of Pediatrics. However, studies looking for any link between allergy, measles infection...
[read article]

New Mouse Model For Peanut Allergy
Chicago researchers report the development of a new mouse model for food allergy that mimics symptoms generated during a human allergic reaction to peanuts. The animal model provides a new research tool that will be invaluable in furthering the...
[read article]

Immunotherapy Alleviates Hay Fever And Asthma In Children
RUB researchers tested grass pollen tablet Study in the Journal of Allergy and Clinical Immunology,Taking one grass pollen tablet every day can alleviate hay fever and asthma in children. These are the results of a study by medical experts in the team led by Prof. Dr. Albrecht Bufe (Experimental Pneumology) ...
[read article]

New Class Of Allergy Drugs May Result From Latest Discovery
If you've ever wondered why some allergic reactions progress quickly and may even become fatal, a new research report published in the February 2009 issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) provides an important part of the answer. In the report, scientists from Queen's...
[read article]

Nothing To Sneeze At: Real-time Pollen Forecasts
Researchers in Germany are reporting an advance toward development of technology that could make life easier for millions of people allergic to plant pollen. It could underpin the first automated, real-time systems for identifying specific kinds of allergy-inducing plant pollen circulating in the air. Their study is in the current..
[read article]

Anti-Allergy Vaccines To Help People With Asthma
Research funded by Asthma UK has led to the development of a vaccine treatment that can prevent asthma-like symptoms in mice.
Dr Noble and his team at King's College London have been studying allergic mechanisms in mice and investigating whether it is possible to regulate the immune system's response to potential allergic triggers. Sometimes the immune ...
[read article]

FDA Approves Astepro - Nasal Antihistamine In The Treatment Of Rhinitis
The U.S. Food and Drug Administration (FDA) has approved Astepro - the new formulation of . Astepro Nasal Spray is an improvement over the marketed Astelin Nasal Spray and is better tolerated by patients using the new spray. The active substance in these products is azelastine - the leading nasal antihistamine in the treatment of rhinitis in the U.S. ...
[read article]

FDA Has Accepted For Filing The First Potential Once-a-Day Nasal Antihistamine
The New Drug Application (NDA) for a newly formulated higher strength azelastine nasal spray has now been accepted by the Food and Drug Administration (FDA) as complete for substantive review after initial evaluation. "This product has the potential to become the first once-a-day nasal antihistamine in the U.S. Beside better tolerance with the new formulation it could ...
[read article]